Sing Medical – Chart seems to be strengthening (13 Feb 2019)

This week, Sing Medical’s (“SMG”) caught my attention. At the time of writing this write-up, SMG is trading +0.005 to $0.430. Day range 0.425 – 0.430.


Some interesting observations on SMG

a) Chart seems to be strengthening

Based on Chart 1 below, SMG seems to have breached the near term downtrend line established since Mar 2018. Today is T+7 of the sharp upmove dated 31 Jan 2019 thus, I guess those contra players (who plan to contra and not hold the stock) have already exited. Indicators such as OBV, RSI and MACD are strengthening. ADX last trades 34.5 on 12 Feb 2019 amid postively placed Dis, indicative of a trend. Except for 200D SMA and 200D EMA, other EMAs are trending higher with a couple of golden cross formations being formed.

Incidentally, DBS also has a bullish technical call on SMG today.

My personal view is that SMG’s chart will turn more bullish if it can make a sustained close above its 200D EMA and 200D SMA (approximately around $0.435-0.440) with volume expansion.

Near term supports: $0.410 – 0.420 / 0.400

Near term resistances: $0.430 – 0.440 / 0.460 / 0.475 – 0.480

Chart 1: SMG chart seems to strengthen

Sing Medical chart 13 Feb 19

Source: InvestingNote 13 Feb 2019

b) Cheap valuations relative to peers

Based on Bloomberg, SMG is trading at approximately 13x FY19F PE and 14x FY18F PE, as compared to sector average 22x FY19F PE and 24x FY18F PE respectively;

c) Low on a one year price basis

Besides trading at lower valuations vis-a-vis peers, SMG is near the lower end of its one year price range $0.380 – 0.580;

d) May have a formal dividend policy and share buy-back mandate in FY19F

Based on SMG’s 3QFY18 results, management mentioned that it may implement a formal dividend policy in FY19F and a share buy-back mandate, subject to all necessary approvals and compliance. This is done so as to enhance shareholder value;

e) May be a beneficiary of of our Singapore budget

Based on a Reuters’ article dated 11 Feb 2019, Singapore has the fastest aging population in the world after South Korea. Coupled with our lengthening life expectancy, health care costs are likely to be a subject in our Singapore budget to be unveiled on 18 Feb 2019.

g) Analysts are generally positive in SMG

With refence to Figure 1 below, analysts polled by Bloomberg are giving target prices for SMG ranging from $0.560 – 0.740.

Figure 1: Analyst target prices range from $0.560 – 0.740

Sing medical analyst target price 12 Feb 19

Source: Blmberg 12 Feb 2019

As usual, for any stock, besides market risk, there are many risks to be aware of. Examples of risks include (but not limited) to the following:

a) No dividends at the moment

As of now, SMG is not giving out any dividends yet; ie no dividend return based on now.

b) Doctors leaving SMG once their lock out periods end;

c) Slowdown in medical tourism;

d) No direct access to management and not familiar with SMG’s specific fundamental;

e) SMG reports 4QFY18F results in the next couple of weeks

As I am not familiar in SMG’s specific fundmentals, I have no visibility in SMG’s upcoming 4QFY18 results. As you are aware, results are an event risk. Results which beat analysts’ estimates coupled with confident outlooks are likely to cause the share price to rise and vice versa.

f) SMG is illiquid

Ave 30D volume is around 179K shares per day only. i.e. It is not an easy stock to enter or exit;



SMG’s chart seems to be strengthening and on the verge of breaching its key resistance $0.430 – 0.440. It has to breach the resistance $0.430 – 0.440 on a sustained basis and with volume expansion for it to be more bullish. Nevertheless, readers should take into account of the above risk factors (note the list of risks is not exhaustive) too. Readers who wish to know more on SMG can refer to SGX for more information and HERE for the analyst reports.


Readers who wish to be notified of my write-ups and / or informative emails, can consider signing up at However, this reader’s mailing list has a one or two-day lag time as I will (naturally) send information (more information, more emails with more details) to my clients first. For readers who wish to enquire on being my client, they can consider leaving their contacts here

P.S: I am vested in SMG for a potential trading play and aim for a few bids of profit if any. I have highlighted SMG to my clients this morning when it is $0.425/0.430. Do note that as I am a full time remisier, I can change my trading plan fast to capitalize on the markets’ movements.



Please refer to the disclaimer HERE

Leave a Reply

Your email address will not be published. Required fields are marked *